Difference between revisions of "PM - Expand & Enhance Prescription Drug Monitoring Program"
(Imported from text file) |
|||
Line 1: | Line 1: | ||
− | <div | + | <div class="mw-parser-output"><div class="wiki" id="content_view" style="display: block"> |
− | + | Return to <u>[[Expand_&_Enhance_Prescription_Drug_Monitoring_Program|Expand & Enhance Prescription Drug Monitoring Program]]</u><br/> <u>Go to [[PO_-_Expand_&_Enhance_Prescription_Drug_Monitoring_Progams|Objective Details]]</u><br/> | |
− | + | ||
− | Return to <u>[[ | + | = Potential Measures = |
− | =Potential Measures= | + | |
− | <span style="color: #ff0000">As you add potential measures, please include a description, calculations for the measure and possible data sources.</span> | + | <span style="color: #ff0000">As you add potential measures, please include a description, calculations for the measure and possible data sources.</span> |
+ | |||
{| class="wiki_table" | {| class="wiki_table" | ||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
− | | | + | | style="text-align: center" | '''Measure''' |
− | | | + | | style="text-align: center" | '''Description''' |
− | | | + | | style="text-align: center" | '''Calculations''' |
− | | | + | | style="text-align: center" | '''Data Source''' |
|- | |- | ||
− | | | + | | Number (#) of Reported Schedule II Prescriptions Filled per Capita |
− | + | | <span style="font-family: Verdana,Arial; font-size: 12px">The number of reported schedule II prescriptions filled (includes all schedule II drugs, not just opioids) per capita (or for each individual person). E.g., a per capita rate of 1.0 means there was one schedule II prescription filled to account for each person in the county, whereas a per capita rate of .5 means there was one schedule II prescription filled to account for every two people in the county.</span> | |
− | | < | + | | |
− | + | | <span style="font-family: Verdana,Arial; font-size: 12px">PDMP Data</span> | |
|- | |- | ||
− | | Percent (%) of | + | | Percent (%) of Providers in the state using the active PDMP system |
− | | The percent of | + | | The percent of providers using the active state system. |
− | | | + | | |
− | | | + | | |
|- | |- | ||
− | | | + | | Percent (%) of Pharmacists in the state actively using the PDMP system |
− | | | + | | The percent of pharmacists using the active state system. |
− | | | + | | |
− | | | + | | |
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|} | |} | ||
− | <br /> | + | |
− | =Data Sources= | + | <br/> |
+ | |||
+ | = Data Sources = | ||
+ | |||
{| class="wiki_table" | {| class="wiki_table" | ||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
− | | | + | | style="text-align: center" | '''Site''' |
− | | | + | | style="text-align: center" | '''Org''' |
− | | | + | | style="text-align: center" | '''Date Added''' |
− | | | + | | style="text-align: center" | '''Comments''' |
+ | |- | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|} | |} | ||
− | </div> | + | </div> </div> |
Revision as of 01:17, 10 January 2019
Return to Expand & Enhance Prescription Drug Monitoring Program
Go to Objective Details
Potential Measures
As you add potential measures, please include a description, calculations for the measure and possible data sources.
Measure | Description | Calculations | Data Source |
Number (#) of Reported Schedule II Prescriptions Filled per Capita | The number of reported schedule II prescriptions filled (includes all schedule II drugs, not just opioids) per capita (or for each individual person). E.g., a per capita rate of 1.0 means there was one schedule II prescription filled to account for each person in the county, whereas a per capita rate of .5 means there was one schedule II prescription filled to account for every two people in the county. | PDMP Data | |
Percent (%) of Providers in the state using the active PDMP system | The percent of providers using the active state system. | ||
Percent (%) of Pharmacists in the state actively using the PDMP system | The percent of pharmacists using the active state system. | ||
Data Sources
Site | Org | Date Added | Comments |